Senior Management
Howard B. Urnovitz, Ph.D., Chief Executive Officer/Chief Science Officer and Co-Founder
Dr. Urnovitz co-founded Chronix Biomedical in 1997, and serves as CEO and CSO. He has been active in corporate biotechnology discovery and research for the past 30 years. Previously, Dr. Urnovitz founded Calypte Biomedical, Inc., a manufacturer of HIV diagnostics, and served as Chief Scientific Officer from 1988-2000. Prior to Calypte Biomedical, Dr. Urnovitz served as Senior Scientist at the Institute of Cancer Research, Medical Research Institute, in San Francisco, California. Previously, he was Director of Molecular and Cellular Engineering at XOMA Corporation in Berkeley, California. Prior to XOMA, he was Director of the Hybridoma Facility, Laboratory of Experimental Pathology at the University of Iowa. Dr. Urnovitz has published in scientific journals, and has been an invited speaker or panelist at international scientific conferences and U.S Congressional hearings. He holds several patents related to immunoassay diagnostics. Dr. Urnovitz received his B.S. and M.S. in Microbiology and a Ph.D. in Microbiology and Immunology from the University of Michigan and completed his post-doctoral studies at Washington University, St. Louis, Missouri.
John DiPietro, Chief Financial Officer
Mr. DiPietro joined Chronix as Chief Financial Officer in 2002. He has over 28 years of experience in financial management, public accounting and senior management of public and private companies. He has successfully completed three IPOs and has raised over $200 million of public/private debt and equity. He served as Chief Financial Officer and Chief Operating Officer of Calypte Biomedical, Inc. from 1995-1999. Previously, Mr. DiPietro served as Chief Financial Officer of Meris Labs, Inc., a clinical laboratory company, and as Chief Financial Officer of Tripath Technology, Inc., a semiconductor company. He is a member of the Board of Directors of Calypte Biomedical, Inc., and serves as Chairman of the Compliance Committee and as a member of the Audit Committee. Mr. DiPietro received his B.S. from Lehigh University and his M.B.A. from the University of Chicago Graduate School of Business. He is a Certified Public Accountant.
Ekkehard Schütz, Vice President Research
Dr. Schütz joined Chronix in 2000 and has 20 years experience in medical laboratory diagnostics. He received his M.D., and Ph.D. in Molecular Diagnostics from the University of Göttingen. Dr. Schütz has over 110 peer reviewed publications and several awards. He is a highly cited and recognized expert in the field of Genetics.
Howard B. Urnovitz, Ph.D., Chief Executive Officer/Chief Science Officer and Co-Founder
Dr. Urnovitz co-founded Chronix Biomedical in 1997, and serves as CEO and CSO. He has been active in corporate biotechnology discovery and research for the past 30 years. Previously, Dr. Urnovitz founded Calypte Biomedical, Inc., a manufacturer of HIV diagnostics, and served as Chief Scientific Officer from 1988-2000. Prior to Calypte Biomedical, Dr. Urnovitz served as Senior Scientist at the Institute of Cancer Research, Medical Research Institute, in San Francisco, California. Previously, he was Director of Molecular and Cellular Engineering at XOMA Corporation in Berkeley, California. Prior to XOMA, he was Director of the Hybridoma Facility, Laboratory of Experimental Pathology at the University of Iowa. Dr. Urnovitz has published in scientific journals, and has been an invited speaker or panelist at international scientific conferences and U.S Congressional hearings. He holds several patents related to immunoassay diagnostics. Dr. Urnovitz received his B.S. and M.S. in Microbiology and a Ph.D. in Microbiology and Immunology from the University of Michigan and completed his post-doctoral studies at Washington University, St. Louis, Missouri.
John DiPietro, Chief Financial Officer
Mr. DiPietro joined Chronix as Chief Financial Officer in 2002. He has over 28 years of experience in financial management, public accounting and senior management of public and private companies. He has successfully completed three IPOs and has raised over $200 million of public/private debt and equity. He served as Chief Financial Officer and Chief Operating Officer of Calypte Biomedical, Inc. from 1995-1999. Previously, Mr. DiPietro served as Chief Financial Officer of Meris Labs, Inc., a clinical laboratory company, and as Chief Financial Officer of Tripath Technology, Inc., a semiconductor company. He is a member of the Board of Directors of Calypte Biomedical, Inc., and serves as Chairman of the Compliance Committee and as a member of the Audit Committee. Mr. DiPietro received his B.S. from Lehigh University and his M.B.A. from the University of Chicago Graduate School of Business. He is a Certified Public Accountant.
Ekkehard Schütz, Vice President Research
Dr. Schütz joined Chronix in 2000 and has 20 years experience in medical laboratory diagnostics. He received his M.D., and Ph.D. in Molecular Diagnostics from the University of Göttingen. Dr. Schütz has over 110 peer reviewed publications and several awards. He is a highly cited and recognized expert in the field of Genetics.
Phone: 408-960-2306 | Email: info@chronixbiomedical.com
Content copyright . Chronix Biomedical. All rights reserved.
